Anxiety Disorder and Depression Treatment Market Size, Status, Share and Forecast By 2018 – 2026

The rise in the graying population and minimal side effects associated with the treatment are some of the factors boosting the market for Anxiety Disorder and Depression Treatment.

Market Size – USD 15.60 Billion in 2018, Market Growth - CAGR of 2.4%, Market Trends –

Increase in awareness regarding mental health.

The Global Anxiety Disorder and Depression Treatment Market is forecast to reach USD18.90 Billion by 2026, according to a new report by Reports and Data. There has been a continued rise in the rate of depression and anxiety in the global healthcare scenario. Such a rise in the incidence rate of depression and anxiety has resulted in focusing on the global healthcare scenario and reduce the incidence rate of such mental healthcare condition. In the year 2018, more than 300 million individuals of all ages were suffering from depression in the global scenario. There have been 800,000 incidents of suicides in the same year, the reason behind which has been primarily, depression and anxiety disorders. Such a rise in the incidence of rate of depression and anxiety are one of the major factors driving the global Anxiety Disorder and Depression Treatment Market.

Globally, incidences of depression and mental health are continuously increasing in the elderly population. This population is prone to mental health issues like dementia, phobia and anxiety disorders. Hence, the increase in the graying population is also contributing to the rising demand for antidepressants and therapies to treat the mental health condition during the forecast period.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/press-release/global-anxiety-disorder-and-depression-treatment-market 

Further key findings from the report suggest

• The rising rate of occurrence of depression and anxiety is one of the contributing factors for the high consumption rate of anti-depressants.
• This rise in the occurrence rate of anxiety and depression is one of the major driving factors for global Anxiety Disorder and Depression Treatment Market, contributing to market growth.
• In the segment Drug class, the highest market share was held by antidepressants, in the year 2018, followed by antidepressants. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) dominated the markets in the year 2018, with a market share of 28%.
• Rise in the occurrence rate of anxiety and depression along with incidents of suicide, the edifice of which were anxiety disorders have also made a positive impact on the global Anxiety Disorder and Depression Treatment M
• As a result of such incidents of suicide, there has been a rise in demand for therapies. In the year 2018, Cognitive Behavior Therapy [CBT] dominated the market with a market share of 30%.
• During the forecast period, CBT is forecasted to hold a market share of 31% by 2026.
• Key participants include Johnson & Johnson, Inc., Pfizer, GlaxoSmithKline plc., Lundbeck A/S, Inc., Sanofi- Aventis, Merck & Company, AstraZeneca PLC., Forest Laboratories, Eli Lilly and Company, Bristol-Myers Squibb Company among

For the purpose of this report, Reports and Data have segmented the global Anxiety Disorder and Depression Treatment Market based on Drug class, Therapies, Devices, Application, End-users, and Region:

Drug class Outlook (Revenue, USD Billion; 2016-2026)

• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Antidepressant Drugs
• Tricyclic Antidepressants (TCAs)
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
• Monoamine Oxidase Inhibitors (MAOIs)
• Benzodiazepines
• Atypical Antipsychotics
• Anticonvulsants
• Beta-Blockers
• Others

Therapies Outlook (Revenue, USD Billion; 2016-2026)

• Electroconvulsive Therapy (ECT)
• Cognitive Behavior Therapy (CBT)
• Psychotherapy
• Deep Brain Stimulation
• Transcranial Magnetic Stimulation (TMS)
• Cranial electrotherapy stimulation (CES)

Devices Outlook (Revenue, USD Billion; 2016-2026)

• Cranial electrotherapy stimulator
• Fisher-Wallace stimulator market

Application Outlook (Revenue, USD Billion; 2016-2026)

• Phobia
• Major Depressive Disorder
• Obsessive Compulsive Disorder (OCD)
• Post-traumatic stress disorder
• Others

End-users Outlook (Revenue, USD Billion; 2016-2026)

• Hospitals
• Mental healthcare centers
• NGOs
• Asylums

Regional Outlook (Revenue, USD Billion; 2016-2026)

• North America
  1. U.S.
• Europe
  1. UK
  2. France
• Asia Pacific
  1. China
  2. India
  3. Japan
• MEA
• Latin America
1. Brazil

Request For Free PDF Sample of This Research Report at: https://www.reportsanddata.com/sample-enquiry-form/1405